Literature DB >> 31182622

U.S. Re-Licensure Opioid/Pain Management Continuing Education Requirements in Dentistry, Dental Hygiene, and Medicine.

R Constance Wiener1, Christopher Waters2, Ruchi Bhandari2, Alcinda K Trickett Shockey2, Fotinos Panagakos2.   

Abstract

Drug-induced deaths have been accelerating over the last two decades. The aim of this study was to determine if states with high opioid-induced deaths and overall drug-induced deaths were more likely to have continuing education (CE) requirements related to opioid use/pain management than states with fewer opioid-induced deaths. Almost 200 state dental and medical law boards' websites were examined for CE requirements, license renewal periods, and CE requirements for opioid use/pain management in December 2018 and January 2019. Drug-induced death data were obtained from the Centers for Disease Control and Prevention online database. States were categorized into quartiles of opioid-induced deaths per 100,000 population. A similar categorization was created for all drug-induced deaths. The results showed that states in the second, third, and fourth quartiles of opioid-induced deaths were more likely to have dental boards requiring opioid use/pain management CE than states in the first quartile in dentistry. This pattern was not the case with the medical boards' requirements. Dentists and physicians in states with higher all drug-induced deaths per 100,000 population were as likely to be required to attend opioid use/pain management CE as dentists and physicians in states with lower opioid-induced deaths. Although many licensing boards require opioid use/pain management CE in relation to their opioid-induced death rates, there is a need for policies to increase education in substance use disorders to reduce the number of drug-induced deaths.

Entities:  

Keywords:  continuing education; dental hygiene; dentistry; drug; medicine; opioid; pain management; public health

Mesh:

Substances:

Year:  2019        PMID: 31182622      PMCID: PMC7561033          DOI: 10.21815/JDE.019.115

Source DB:  PubMed          Journal:  J Dent Educ        ISSN: 0022-0337            Impact factor:   2.264


  19 in total

1.  Continuing dental education requirements for relicensure in the United States.

Authors:  Titus K L Schleyer; David Dodell
Journal:  J Am Dent Assoc       Date:  2005-10       Impact factor: 3.634

2.  Covering the Prescription Drug Monitoring Program Gap: Using Shared Decision Making to Reduce Dental Opioid Prescriptions.

Authors:  Tim T Wang; Elliot V Hersh; Neeraj Panchal
Journal:  J Oral Maxillofac Surg       Date:  2018-08-22       Impact factor: 1.895

3.  Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria.

Authors:  Joseph A Boscarino; Margaret R Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Stephen Ross; Glenn S Gerhard; Walter F Stewart
Journal:  J Addict Dis       Date:  2011 Jul-Sep

4.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

5.  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

Authors:  D Davis; M A O'Brien; N Freemantle; F M Wolf; P Mazmanian; A Taylor-Vaisey
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

6.  Comparison of Dental Students' Self-Evaluation and Faculty Evaluation of Communication Skills During a Standardized Patient Exercise.

Authors:  R Constance Wiener; Christopher Waters; Joan Doris; Daniel W McNeil
Journal:  J Dent Educ       Date:  2018-10       Impact factor: 2.264

7.  Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements.

Authors:  Corey S Davis; Derek Carr
Journal:  Drug Alcohol Depend       Date:  2016-04-20       Impact factor: 4.492

8.  Patterns of abuse among unintentional pharmaceutical overdose fatalities.

Authors:  Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi
Journal:  JAMA       Date:  2008-12-10       Impact factor: 56.272

Review 9.  Emergency medical services naloxone access: a national systematic legal review.

Authors:  Corey S Davis; Jessica K Southwell; Virginia Radford Niehaus; Alexander Y Walley; Michael W Dailey
Journal:  Acad Emerg Med       Date:  2014-10       Impact factor: 3.451

10.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

View more
  1 in total

1.  Medication Prescribing Practices in Croatian Dental Offices and Their Contribution to National Consumption.

Authors:  Ivana Šutej; Dragan Lepur; Darko Božić; Katja Pernarić
Journal:  Int Dent J       Date:  2021-02-26       Impact factor: 2.607

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.